New Psoriasis Clinical Trials in Little Rock Ar
Psoriasis research in Little Rock focuses on localized treatments and patient-specific therapies. Studies at UAMS and associated clinics investigate the impact of biologics and phototherapy on plaque psoriasis severity. Recent research explores genetic predispositions within the Arkansas population and the efficacy of telemedicine for improved patient access and monitoring. Clinical trials are actively enrolling.
Am I Eligible?
Check if you qualify for the Up to $1,200 compensation.
100% Free • No Insurance Required
Local Medical Insight
Location
The research center is conveniently located in Little Rock Ar. Validation parking is provided for all visits. (Specific address revealed upon qualification).
Qualification
- Age 18 - 65
- Diagnosed with Psoriasis
- Trying to find better management options
Available Trials in Little Rock Ar
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Maximal Usage Pharmacokinetics and Safety Study of ARQ-154 Foam 0.3% in Pediatric Participants With Scalp and Body Psoriasis
Environmental Factors in Little Rock Ar
Little Rock's humid subtropical climate can exacerbate psoriasis symptoms, particularly during summer months due to increased sweating and skin irritation. Pollen levels may also trigger flares in sensitive individuals. Urban air quality variations near industrial areas may contribute to inflammation. Access to dermatological care is a key factor.